Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Hesperetin
Cat. No.:
OB0225LY-0204
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Hesperetin is a flavonoid compound with antioxidant and anti-inflammatory properties.
Synonym:
520-33-2; 3',5,7-Trihydroxy-4'-methoxyflavanone; (-)-Hesperetin; (S)-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one; Cyanidanon 4'-methyl ether 1626; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one
CAS No.:
520-33-2
Compound CID:
72281
Formula:
C16H14O6
Formula Weight:
302.28
Specification
Relative Density:
1.458 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Hesperetin can be used to study its potential role in cytoprotection, antioxidant activity, and anti-inflammatory processes.
Library Information
Targets:
GPCR superfamily; MAPK family; TGF-β receptor family
Receptors:
5-HT receptor; p38 MAPK; TGF-β receptor
Pathways:
GPCR/G protein; Autophagy; Apoptosis; MAPK; Stem cells; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 148.87 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
ALogP:
2.357
HBA_Count:
3
HBD_Count:
3
Rotatable Bond:
2
